Kyowa Hakko Kirin’s Neulasta meeting better health insurance benefits
The health insurance standards of Kyowa Hakko Kirin Korea’s Neulasta Prefilled Syringe(generic name: pegfilgrastim) has been partially extensively applied since 1 April.
Neulasta is a daily long-acting drug out of granulocyte colony-stimulating factor(G-CSF) drugs prescribed to decrease incidenc...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.